Improved analgesia and reduced post-operative nausea and vomiting after implementation of an Enhanced Recovery After Surgery (ERAS) pathway for total mastectomy
BMC Anesthesiology Apr 22, 2018
Chiu C, et al. - In this retrospective study, researchers describe the implementation and efficacy of an Enhanced Recovery After Surgery (ERAS) pathway for total skin-sparing mastectomy with immediate reconstruction in all American Society of Anesthesiology (ASA) Class 1–3 patients in an outpatient setting. Preoperative acetaminophen, gabapentin, and scopolamine; regional anesthesia for the breast (Pectoral blocks type 1 and 2 or paravertebral block); and intraoperative dexamethasone and ondansetron were the highlights of the ERAS pathway. In a 23-h-stay hospital, it was feasible to implement an ERAS pathway for total skin-sparing mastectomy with reconstruction that incorporates regional anesthesia. Improved post-operative analgesia and attenuated post-operative nausea and vomiting were observed among patients in the ERAS pathway.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries